Radiation oncology

August 1997
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS82
Academic Journal
Presents an abstract of the research manuscript `Does Ontario provide equitable access to treatment for patients with lung cancer?,' by P. Dixon et al.


Related Articles

  • End-of-Life Care for Advanced Lung Cancer Differs Between U.S. and Canadian Patients. McBride, Deborah // ONS Connect;Aug2011, Vol. 26 Issue 8, p21 

    The article offers information on the findings of a comparative study on end-of-life care for older patients with non-small cell lung cancer (NSCLC) in the U.S. and Ontario, Canada. The study used U.S. Surveillance, Epidemiology, and End Results and Medicare data and data from the Ontario,...

  • Palliative Care in Advanced Cancer Patients: How and When? BRUERA, EDUARDO; YENNURAJALINGAM, SRIRAM // Oncologist;Feb2012, Vol. 17 Issue 2, p267 

    Cancer patients develop severe physical and psychological symptoms as a result of their disease and treatment. Their families commonly suffer great emotional distress as a result of caregiving. Early palliative care access can improve symptom control and quality of life and reduce the cost of...

  • Lung Cancer Treatment Disparities in China: A Question in Need of an Answer. Lu-Lu Yang; Xu-Chao Zhang; Xue-Ning Yang; Jin-Ji Yang; Zhen Wang; Hua-Jun Chen; Hong-Hong Yan; Chong-Rui Xu; Ji-Lin Guan; Yan-Yan He; Wen-Zhao Zhong; She-Juan An; Yi-Long Wu // Oncologist;Oct2014, Vol. 19 Issue 10, preceding, following p1084 

    Background. Substantial progress has been made in the treatment of malignancies in the People’s Republic of China in recent years.The goal of this study was to identify the extent to which national treatment guidelines are being used to customize patient care in lung cancer and to analyze...

  • Inequalities in non-small cell lung cancer treatment and mortality. Nur, Ula; Quaresma, Manuela; De Stavola, Bianca; Peake, Michael; Rachet, Bernard // Journal of Epidemiology & Community Health;Oct2015, Vol. 69 Issue 10, p985 

    Background Non-small cell lung cancer (NSCLC) comprises approximately 85% of all lung cancer cases, and surgery is the preferred treatment for patients. The National Health Service established Primary Care Trusts (PCTs) in 2002 to manage local health needs. We investigate whether PCTs with a...

  • Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588... Sause, William T.; Scott, Charles // JNCI: Journal of the National Cancer Institute;2/1/95, Vol. 87 Issue 3, p198 

    Reports on the results of clinical trials conducted by the Radiation Therapy Oncology Group (RTOG) and the Eastern Cooperative Oncology Group (ECOG) using innovative radiation delivery techniques and the addition of chemotherapy in the treatment of non-small cell lung cancer. Acceptable...

  • Lung cancer: Treating the untreatable.  // Patient Care;3/15/1998, Vol. 32 Issue 5, p18 

    Presents information on lung cancer and its treatment. Reference to lung cancer being the greatest neoplastic killer of Americans; Relation to photodynamic treatment with porfimer sodium (Photofrin) being approved by the Food and Drug Administration (FDA) for inoperable esophageal cancer;...

  • Veggies may shield women against cancer... Capwell, Martha // Prevention;Oct92, Vol. 44 Issue 10, p36 

    Reports that a diet rich in vegetables and high in carotene is linked to lower risk of lung cancer in nonsmokers. Evidence found by epidemiologists in Florida in 124 women with lung cancer; Heavy consumption of both vegetables and fruits reduce the risk of breast cancer.

  • Wider use of lung cancer drug.  // FDA Consumer;Jul/Aug94, Vol. 28 Issue 6, p3 

    Reports that the wider use of Vinorelbine tartrate, an investigational lung cancer drug, has been approved by the Food and Drug Administration (FDA). Plans to market the drug under the name Navelbine; Investigational New Drug (IND) regulations.

  • Re: Five-day oral etoposide treatment for advanced small-cell lung cancer: Randomized... Pfeiffer, Per; Rytter, Carsten; Madsen, Ebbe Lindegaard; Moeholt, Kirsten; Hansen, Olfred; Bentzen, Soren; Palshof, Torben; Rose, Carsten // JNCI: Journal of the National Cancer Institute;12/17/97, Vol. 89 Issue 24, p1892 

    Investigates whether single-agent, daily, oral etoposide is an effective, palliative therapy for advanced small-cell lung cancer as compared with combination therapy. Bioavailability of oral etoposide; Comparison of tumor response to oral etoposide and combination therapy in patients with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics